Your session is about to expire
← Back to Search
Amantadine for Stroke Recovery (PRESTA Trial)
PRESTA Trial Summary
This trial will test whether amantadine can help people recover from a stroke. Patients will be randomly assigned to either take amantadine or a placebo, and will be monitored for recovery over the course of 3 months.
PRESTA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPRESTA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PRESTA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have Parkinson's disease.I am currently taking medication for muscle spasms or bladder issues.I have had seizures in the past.I have had a limb amputated.You have had severe depression, suicidal thoughts, or attempts in the last year.My kidneys are functioning well, with a creatinine clearance rate of 60 mL/min or more.Your stroke severity score is between 3 and 15 on the NIH Stroke Scale.I am eligible for acute rehabilitation or the Homeward Stroke Program.I was diagnosed with dementia or mild cognitive impairment before my stroke.I was admitted for a bleeding in the brain detected by CT or MRI.I have difficulty understanding spoken or written language.I have significant difficulty speaking or finding words.I have previously been treated with amantadine.I am between 18 and 85 years old.I was mostly independent before my stroke.Your liver function tests show high levels of certain enzymes.You are allergic to amantadine.I have had a stroke that left me with lasting effects.I am currently receiving treatment for cancer.I have used or am using medication for mental health issues.I have successfully completed a swallow test.I have had a stroke confirmed by a specialist or through imaging tests.I had a stroke between 24 hours and 3 weeks ago.
- Group 1: Amantadine
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age cap for this research project 75 years old or younger?
"This clinical trial is open to applicants aged 18-85, with 40 studies specifically for those under the age of majority and 1055 others for individuals over 65."
Is it feasible for me to join the ongoing clinical trial?
"This medical trial seeks to recruit approximately 60 individuals who have experienced a hemorrhagic stroke and are aged between 18 and 85 years."
How many participants are enrolled in this experiment?
"Affirmative. Clinicaltrials.gov displays that this clinical trial, which was initially uploaded on February 1st 2022, is currently accepting applications. 60 participants are required to be sourced from a single medical centre."
What measures are being taken to ensure the security of Amantadine for human consumption?
"Due to the lack of evidence for Amantadine's efficacy, our experts at Power assigned it a score of 2 on their safety scale."
Are there opportunities for volunteers to partake in this research experiment?
"Affirmative. Clinicaltrials.gov records show that this research is currently sourcing applicants, with the trial having originally been posted on February 1st 2022 and last updated on December 2nd 2022. 60 volunteers are expected to be recruited from a single medical centre."
What medical conditions is Amantadine typically employed to treat?
"Amantadine can be employed to ameliorate abnormal involuntary movement, parkinsonism post encephalitic, and restless legs syndrome. Additionally, it may be prescribed for prophylactic measures against contracting influenza A virus."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger